ELEVANCE HEALTH INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$420.07
-0.46%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+10.1%
3 months
+10.2%
6 months
+13.7%
1 year
+33.1%
Year to date
+21.6%
52-week range
$276.72 – $445.28
Fundamental snapshot
Latest reported period: Sep 30, 2026
Market cap
$90.76B
P/E
17.7
P/B
2
P/S
0.4
Revenue
$201.83B
Net income
$5.14B
Diluted EPS
23.52
Gross margin
15.50%
Net margin
2.50%
Return on equity
11.60%
Total debt
$30.76B
Cash
$10.35B
Free cash flow
$6.51B
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 30, 2026 | $51.43B | $1.37B | 15.60% | 2.70% | $1B |
| Jun 30, 2026 | $50.47B | $1.46B | 15.80% | 2.90% | $1.63B |
| Mar 31, 2026 | $50.18B | $1.76B | 18.10% | 3.50% | $4.1B |
| Dec 31, 2025 | $49.75B | $547M | 12.40% | 1.10% | -$209M |
| Sep 30, 2025 | $50.71B | $1.19B | 14.20% | 2.30% | $775M |
| Jun 30, 2025 | $49.78B | $1.74B | 15.60% | 3.50% | $1.79B |
| Mar 31, 2025 | $48.89B | $2.18B | 17.60% | 4.50% | $821M |
| Dec 31, 2024 | $45.44B | $418M | 13.00% | 0.90% | $384M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ELV news
All market newsNo ticker-linked stories are in the current archive.